Neurogenic Bladder and Multiple Sclerosis

There have been presented general information of neurogenic bladder and the data on pathophysiology of lower urinary tract dysfunction in patients with multiple sclerosis. The characteristics of clinical presentations of neurogenic bladder in multiple sclerosis have been stated. There have been considered diagnosis and treatment problems of urinary disorders in patients with multiple sclerosis.

1. Gusev E.I., Boyko A.N. Ross Med Z 2001; 1: 4–10.
2. Mazo E.B., Zavalishin I.A., Krivoborodov G.G., Shvarts P.G. Nevrologicheskiy zhurnal 2002; 4: 4–7.
3. Rasseyannyy skleroz [Multiple sclerosis]. Pod. red. I.D. Sto­lyarova, B.A. Osetrova [I.D. Stolyarov, B.A. Osetrov (editors)]. Saint Petersburg; 2002; 176 p.
4. Shvarts P.G. Narushenie akta mocheispuskaniya u bol’nykh rasseyannym sklerozom remitiruyushchego techeniya. Avtoref. dis. … kand. med. nauk [Urination disorders in patients with remittent multiple sclerosis. Abstract of Dissertation for the degree of Candidate of Medical Science]. Moscow; 2004.
5. McCombe P.A., Gordon T.P., Jackson M.W. Bladder dysfunction in multiple sclerosis. Expert Rev Neurother 2009; 9(3): 331–340.
6. Motta R., de Carvalho M.L. Management of bladder dysfunction in multiple sclerosis patients: the nurse’s point of view. Neurol Sci 2008; 29(Suppl 4): 356–359.
7. Nortvedt M.W., Riise T., Frugrd J., Mohn J., Bakke A., Skr A.B., Nyland H., Glad S.B., Myhr K.M. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007; 13(1): 106–112.
8. Wein A.J. Neuromuscular dysfunction of lower urinary tract. In: Campbell’s Urology. P. Walsh, E. Vaughan, A. Wein (ed.). W.B. Saunders Company; 1998; p. 905–1005.
9. De Sze M., Ruffion A., Denys P., Joseph P.A., Perrouin-Verbe B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007; 13(7): 915–928.
10. Shmidt T.E., Yakhno N.N. Rasseyannyy skleroz [Multiple sclerosis]. Moscow: Meditsina; 2003; 160 p.
11. Fowler C. Bladder dysfunction in multple sclerosis: causes and treatment. MS Forum: the International MS Journal 1995; 1(3): 99–107.
12. Fowler C., van Kerrebroeck P., Nordendo A. et al. Treatment of lower urinary tract dysfunction in patients with multple sclerosis. J Neurol Neurosurg Psychiatry 1992; 55: 986–989.
13. Rasseyannyy skleroz. Diagnostika, lechenie, spetsialisty [Multiple sclerosis. Diagnostics, treatment, specialists]. Pod. red. I.D. Stolyarova, A.N. Boyko [I.D. Stolyarov, A.N. Boyko (editors)]. Saint Petersburg: ELBI-SPb; 2008; 320 .
14. Pellat G.C. Neurogenic continence. Part 1: pathophysiology and quality of life. Br J Urol 2008; 17(13): 836–841.
15. Vishnevskiy E.L., Loran O.B., Vishnevskiy A.E. Klinicheskaya otsenka rasstroystv mocheispuskaniya [Clinical evaluation of urinary discomfort]. Moscow: Moskva-Terra; 2001.
16. Dzhavad-Zade M.D., Derzhavin A.M. Neyrogennye disfunktsii mochevogo puzyrya [neurogenic dysfunction of urinary bladder]. Moscow: Meditsina; 1989.
17. Savchenko N.E., Mokhort V.A. Neyrogennye rasstroystva mocheispuskaniya [Neurogenic urinary discomfort]. Minsk: Belarus’; 1970.
18. Cardenas D., Mayo M., King J. Urinary tract and bowel management in the rehabilitation setting. In: R. Braddom (ed.). Physical medicine and rehabilitation. W.B. Saunders Company; 1996; p. 555–579.
19. Erickson R. Autonomic hyperreflexia: pathophysiology and medi­cal management. Arch Phys Med Rehab 1980; 61: 431–440.
20. Bogdanov E.I. Nevrologicheskiy vestnik 1995; XXVII(3–4): 28–34.
21. Lur’e Z.L. Nevrogennye rasstroystva mocheispuskaniya. V kn.: Voprosy prakticheskoy urologii [Neurogenic urinary discomfort. In the book: Practical urology issues]. Pod. red. A.P. Frumkina [A.P. Frumkin (editor)]. Moscow; 1949; p. 119–133.
22. Shtul'man D.R. Neyrogennyy mochevoy puzyr'. V kn.: Bolezni nervnoy sistemy [Neurogenic urinary bladder. In: Nervous system diseases]. Pod red. N.N. Yakhno, D.R. Shtul’mana [N.N. Yakhno, D.R. Shtul’man (editor)]. Vol. 1. Moscow: Medi­tsina; 2003; p. 167–169.
23. McLellan F.C. The neurogenic bladder. Springfield, Thomas; 1939.
24. Abrams P., Cardozo L., Fall M. et al. The standartization of terminology in lower urinary tract function. 2002; 21: 167–178.
25. Betts C.D., D’Mellow M.T., Fowler C. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 245–250.
26. Blaivis J.G., Kaplan S.A. Urologic dysfunction in patients with multiple sclerosis. Semin Urol 1988; 8: 159.
27. Chancellor M.B., Blaivas J.G. Multiple sclerosis. Prob Urol 1993; 7(1): 15–33.
28. Sirls L.T., Zimmern P.E., Leach G.E. Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 1994; 151: 946.
29. Mayo M.E., Chetner M.P. Lower urinary tract dysfunction in multiple sclerosis. Urology 1992; 39: 67.
30. Demina M.L., Popova N.F. Сonsilium Medicum 2002; 4(2): 92–96.
31. Miller H., Simpson C.A., Yeates W.K. Bladder dysfunction in multiple sclerosis. Br Med J 1995; 1: 1265–1269.
32. Blaivas J.G., Sinha H.P., Zayed A.A.H. et al. Detrusor-external sphincter dyssynergia. J Urol 1981; 125: 545.
33. Lemack G.E., Frohman E., Ramnarayan P. Women with voi­ding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly ele­vated intravesical pressures. Urology 2007; 69(5): 893–897.
34. Bradley W.E. Urinary bladder dysfunction in multple sclerosis. Neurology 1978; 28: 52–58.
35. Petersen T., Pedersen N. Neurourodinamic evaluation of voiding dysfunction in multple sclerosis. Acta Neurol Scand 1984; 69: 402–411.
36. Taylor R.S. Rehabilitation of persons with multple sclerosis. In: Physical medicine and Rehabilitation. R. Braddom (ed.). W.B. Saunders company; 1996; р. 1101–1112.
37. Barry M., Fowler F.J., O’Leary M. et al. AUA Measurement Committee: the American Urological Assosiation symptom index for bening prostatic hyperplasia. J Urol 1992; 148: 551–554.
38. O’Leary M. Evaluating symptoms and functional status in be­ning prostate hyperplasia. Br J Urol 1995; 76: 25.
39. Dobrokachestvennaya giperplaziya predstatel'noy zhelezy [Benign prostatic hyperplasia]. Pod. red. A.N. Lopatkina [A.N. Lo­patkin (editor)]. Moscow, 1997.
40. Del Popolo G., Panariello G., Del Corso F., De Scisciolo G., Lombardi G. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 2008; 29(Suppl 4): 352–355.
41. Nordendo A., van Kerrebroeck P., van Poppel H. et al. Treatment of lower urinary tract dysfunction in patients with MS. J Neurol Neurosurg Psychiatry 1993; 56: 1137.
42. Madercbacher H., Jild G. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride. Paraplegia 1991; 29: 84–90.
43. Weese D., Roskamp D., Leach G. et al. Intravesical oxybutynin chloride: experience with 42 patients. Urology 1993; 41: 527–530.
44. Demina T.L., Stankovich E.Yu. Simptomaticheskoe lechenie narusheniy funktsii nizhnikh mochevykh putey u bol’nykh rasseyannym sklerozom [Symptomatic treatment of lower urinary tract dysfunction in patients with multiple sclerosis]. Moscow; 2002.
45. Amend B., Hennenlotter J., Schfer T., Horstmann M., Stenzl A., Sievert K.D. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol 2008; 53(5): 1021–1028.
46. Maggi C.A., Santicioli P., Borsini F. et al. The role of the capsaicin-sensitive innervation of the rat urinary bladder in the activation of micturition reflex. Naunyn-Schmiedeberg’s Arch Pharmacol 1986; 322: 276–283.
47. De Croat W., Kawatani T., Hisamitsi T. Mechanisms under­lying the recovery of urinary bladder function following spinal cord injury. J Aunonom Nerv Syst 1990; 30: S71–S78.
48. Krivoborodov G.G., Mazo E.B., Shvarts P.G. Urologiya 2002; 5: 36–39.
49. Kabay S.C., Yucel M., Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology 2008; 71(4): 641–645.
50. Tanagho E., Schmidt R., Orvis B. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathis voiding disorders. J Urol 1989; 142: 340–345.
51. Kalsi V., Gonzales G., Popat R., Apostolidis A., Elneil S., Dasgupta P., Fowler C.J. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 2007; 62(5): 452–457.
52. Centonze D., Petta F., Versace V., Rossi S., Torelli F., Prosperetti C., Rossi S., Marfia G.A., Bernardi G., Koch G., Miano R., Boffa L., Finazzi-Agr E. Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Mult Scler 2007; 13(2): 269–271.
53. Hilton P., Hertogs K., Stanton S. The use of desmopressin for nocturia in women with multple sclerosis. J Neurol Neurosurg Psychiatry 1983; 46: 854–855.
54. Ferreira E., Letwin S.R. Desmopressin for nocturia and enuresis associated with multple sclerosis. Ann Pharmacother 1998; 32: 114–116.
55. Hoverd P.A., Fowler C.J. Desmopressin in the treatment of daytime urinary frequency in patients with multple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65: 778–780.
56. Gusev E.I., Boyko A.N. Rasseyannyy skleroz: ot izucheniya immunopatogeneza k novym metodam lecheniya [Multiple sclerosis: from the study of immunopathogenesis to new treatment techniques]. Moscow; 2001.
57. Guttmann L., Frankel H. The value of intermitten cateterization in the early management of traumatic paraplegia and tetraplegia. Paraplegia 1966; 4: 63–84.
58. Lapides J., Diokno A.C., Lowe B.S. Follow up on unsterile, intermitten self-catheterization. J Urol 1974; 111: 184–187.
59. Webb R.J., Lawson A.L., Neal D.E. Clean intermitten self-catheterization in 172 adults. Br J Urol 1990; 65: 20–23.
60. Vahter L., Zopp I., Kreegipuu M., Kool P., Talvik T., Gross-Paju K. Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction. Mult Scler 2009; 15(3): 379–384.
61. Diagnostika i lechenie rasseyannogo skleroza [Diagnosis and treatment of multiple sclerosis]. Pod red. I.O. Stepanova, N.N. Spi­rina [I.O. Stepanov, N.N. Spirin (editor)]. Yaroslavl’; 2001.
62. Das Gupta P., Flasman C., Goodwin R.J., Fowler C.J. Emptying the neurogenic bladder. Br J Urol 1997; 80: 234–237.
63. Barnes D.G., Shaw P.J., Timoney A.G. et al. Management of neuropathic bladder by suprapubic catheterization. Br J Urol 1993; 72: 169–172.
64. Marrie R.A., Cutter G., Tyry T., Vollmer T., Campagnolo D. Disparities in the management of multiple sclerosis-related bladder symptoms. Neurology 2007; 68(23): 1971–1978.

Krupin V.N., Belova А.N. Neurogenic Bladder and Multiple Sclerosis. Sovremennye tehnologii v medicine 2011; (4): 126